Drawing for PHELIX

USPTO serial 87741594

PHELIX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RIRIE, VERNA BETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHELIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lee J. Eulgen

Lee J. Eulgen NEAL GERBER & EISENBERG LLPTWO NORTH LASALLE STREETSUITE 1700CHICAGO, IL 60602

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and the treatment of infectious diseases; pharmaceutical preparations and substances for use in immune therapy, the treatment of infectious diseases, the treatment of damaged skin and tissue, inflammation, blood disorders, and viral diseases and disordersACTIVE—
010Therapeutic medical devices for withdrawing blood from the body, separating the blood, treating the blood extracorporeally, and returning the blood to the body; therapeutic medical device used for extracorporeal photopheresis, extra corporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and the treatment of infectious diseasesACTIVE—
044Therapeutic medical treatment services relating to extracorporeal photopheresis, extra corporeal photo immune therapy, extracorporeal photo chemotherapy, cellular therapies, and the treatment of infectious diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 23, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 23, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 5, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 4, 2021EX5GSOU EXTENSION 5 GRANTED—
Dec 21, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 8, 2020EXT5SOU EXTENSION 5 FILED—
Dec 8, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 29, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 27, 2020EX4GSOU EXTENSION 4 GRANTED—
May 27, 2020EXT4SOU EXTENSION 4 FILED—
May 27, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 9, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 7, 2020EX3GSOU EXTENSION 3 GRANTED—
Jan 7, 2020EXT3SOU EXTENSION 3 FILED—
Jan 7, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 26, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 24, 2019EX2GSOU EXTENSION 2 GRANTED—
Jun 24, 2019EXT2SOU EXTENSION 2 FILED—
Jun 24, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 11, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 7, 2018EX1GSOU EXTENSION 1 GRANTED—
Dec 7, 2018EXT1SOU EXTENSION 1 FILED—
Dec 7, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 17, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 22, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 22, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 2, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 12, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 12, 2018DOCKASSIGNED TO EXAMINER—
Jan 17, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 6, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance